| 1 |
|
A randomised comparison of two inactivated hepatitis A vaccines, Avaxim&trade and Vaqta&rade, given as a booster to subjects primed with Avaxim&trade/
|
Clarke, Paul
|
Butterworths
|
2001
|
|
|
|
| 2 |
|
A randomized double-blind trial comparing a two-component acellular to awhole-cell pertussis vaccine in Senegal
|
Simondon, F
|
Butterworths
|
1997
|
|
|
|
| 3 |
|
A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine
|
Drabick, J. J
|
Butterworths
|
1997
|
|
|
|
| 4 |
|
A randomized study of a flexible booster dosing regimen of VAQTA(R) in adults: safety, tolerability, and immunogenicity/
|
Hornick, Richard
|
Butterworths
|
2001
|
|
|
|
| 5 |
|
A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability/
|
Sander, P
|
Butterworths
|
2003
|
|
|
|
| 6 |
|
A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge
|
Fischer, L
|
Butterworths
|
1997
|
|
|
|
| 7 |
|
A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus/
|
Johnson, M. A
|
Butterworths
|
2003
|
|
|
|
| 8 |
|
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen
|
Davis, D
|
Butterworths
|
1997
|
|
|
|
| 9 |
|
A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model/
|
Liljestr�m, Peter; Sheahan, Brian J; Morris-Downes, Margaret M Atkins, Gregory J Fleeton, Marina N; Reid, Hugh W;
|
Butterworths
|
2001
|
|
|
|
| 10 |
|
A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics
|
Hanlon, C. A
|
Butterworths
|
1997
|
|
|
|
| 11 |
|
A right to mislead Parliament?
|
Tomkins, A
|
Butterworths
|
1996
|
|
|
|
| 12 |
|
Rabies and rabies research: past, present and future
|
Zhen Fang Fu
|
Butterworths
|
1997
|
|
|
|
| 13 |
|
Rabies DNA vaccine in the horse: strategies to improve serological responses/
|
Fischer, L
|
Butterworths
|
2003
|
|
|
|
| 14 |
|
Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine
|
Trimarchi, C. V. Esposito, J. J. Ngichabe, C. Hu, L.
|
Butterworths
|
1997
|
|
|
|
| 15 |
|
Randomised controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at two, three and four months of age
|
Jones, I. G
|
Butterworths
|
1998
|
|
|
|
| 16 |
|
Randomized, comparative trial of 20 � vs 40 � Engerix B vaccine in hepatitis B vaccine non-responders
|
Goldwater, P. N
|
Butterworths
|
1997
|
|
|
|
| 17 |
|
Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity/
|
Ehrlich, H. J
|
Butterworths
|
2003
|
|
|
|
| 18 |
|
Rapid identification of Newcastle disease virus vaccine strains LaSota and B-1 by restriction site analysis of their matrix gene
|
Wehmann, E. Ballagi-Pordany, A. Lomniczi, B. Herczeg, J.
|
Butterworths
|
1997
|
|
|
|
| 19 |
|
Rapid onset of malaria-induced mortality by immunizations with lipo-peptides: an experimental model to study deleterious immune responses and immunopathology in malaria
|
Reed, R. C
|
Butterworths
|
1997
|
|
|
|
| 20 |
|
Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States
|
Bernstein, H. H
|
Butterworths
|
1995
|
|
|
|
기사
(116)
